Katherine Leibowitz Speaking – May 15, 2026 | Strafford CLE: AI Clauses in Clinical Trial Agreements

We are excited to announce that Katherine Leibowitz will be co-presenting a Strafford webinar, “AI Clauses in Clinical Trial Agreements: Drafting and Negotiation Strategies; Due Diligence; Pitfalls to Avoid” on Friday, May 15, 2026.

Katherine will join Istvan Fekete and David Peloquin to examine how clinical trial agreements (CTAs) are evolving to account for the use of artificial intelligence in trial administration and operations. The program will cover:

• Where AI is currently being used across trial workflows
• Federal and state regulatory considerations
• “No AI” and controlled-use clauses
• Integration of AI terms with core CTA provisions (e.g., data rights, liability, compliance)
• Informed consent, data-sharing frameworks, and vendor oversight
• Common drafting gaps and emerging negotiating positions

The session includes a live Q&A.

Details

Friday, May 15, 2026
1:00–2:30 p.m. Eastern
CLE credit available

As part of our network, you are eligible to register at 50% off.  For more information, please click the link below and use the promo code at checkout:
Registration Link

Promo Code: Leibowitz 05Z1xIAEACV2

As AI becomes embedded across trial operations, the contracting issues are no longer theoretical. Addressing how these tools are used, and how risk is allocated, is becoming a core part of CTA drafting and negotiation.